Condition
Advanced Refractory Left Ventricular Heart Failure
Total Trials
6
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
4 of 6 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed6
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04548128CompletedPrimary
Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS
NCT02170363Not ApplicableCompletedPrimary
HeartMate 3™ CE Mark Clinical Investigation Plan
NCT02892955Not ApplicableCompletedPrimary
MOMENTUM 3 Continued Access Protocol
NCT02224755Not ApplicableCompletedPrimary
MOMENTUM 3 IDE Clinical Study Protocol
NCT03022461CompletedPrimary
HeartMate 3 CE Mark Study Long Term Follow-up
NCT03982979CompletedPrimary
MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS
Showing all 6 trials